Seong-Jin Kim
Founder bij MEDPACTO, INC.
Vermogen: 24 M $ op 31-03-2024
Profiel
Seong-Jin Kim is the founder of MedPacto, Inc., Celloram, Inc. He is currently the Head of the Cancer Institute at CHA University.
Previously, he worked as an Independent Director and Head of Research & Development at THERAGEN ETEX Co., Ltd.
He holds a doctorate degree from the University of Tsukuba.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
MEDPACTO, INC.
6.40% | 22-12-2023 | 2 149 334 ( 6.40% ) | 21 M $ | 31-03-2024 |
THERAGEN ETEX CO., LTD
3.26% | 31-12-2022 | 1 059 025 ( 3.26% ) | 3 M $ | 31-03-2024 |
Actieve functies van Seong-Jin Kim
Bedrijven | Functie | Begin |
---|---|---|
MEDPACTO, INC. | Founder | 19-06-2013 |
CHA University | Corporate Officer/Principal | 01-07-2011 |
Celloram, Inc.
Celloram, Inc. BiotechnologyHealth Technology Celloram, Inc. develops cellular immunotherapies to fight against cancer and metabolic disorders. The company is based in Cleveland, OH. The company was founded in 2018 by John Letterio, Seong-Jin Kim. The CEO is Tej Pareek. | Founder | - |
Eerdere bekende functies van Seong-Jin Kim
Bedrijven | Functie | Einde |
---|---|---|
THERAGEN ETEX CO.,LTD. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Seong-Jin Kim
University of Tsukuba | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
THERAGEN ETEX CO.,LTD. | Health Technology |
MEDPACTO, INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Celloram, Inc.
Celloram, Inc. BiotechnologyHealth Technology Celloram, Inc. develops cellular immunotherapies to fight against cancer and metabolic disorders. The company is based in Cleveland, OH. The company was founded in 2018 by John Letterio, Seong-Jin Kim. The CEO is Tej Pareek. | Health Technology |